NCAM1 and neoplasm: The anti-tumor activity of CIK cells is mostly owing to the high proliferative and cytolytic potential of CD3+CD56+ NKT cells, which increased about 100 to 1000 folds and mediated by the interaction of NKG2D receptor with MHC-unrestricted ligands on tumor cells [1], [22], [23].